Solventum Corp (SOLV): Healthcare’s Wild Card
Solventum Corporation (NYSE: SOLV) is a healthcare company that recently began trading on the New York Stock Exchange following its spin-off from 3M’s healthcare business in April 2024. The company is headquartered in Saint Paul, Minnesota, and operates through four main segments: Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration.
Solventum’s products and services are designed to address critical needs in the healthcare industry, including advanced wound care, surgical supplies, dental and orthodontic products, health information software, and purification technologies. The company employs approximately 22,000 people and had sales of $8.2 billion in 2023 while still part of 3M.
The company is focused on leveraging its strong innovation capabilities and trusted brands to enhance healthcare delivery. Its products are used globally, contributing to higher quality patient care, improved safety standards, and more efficient healthcare processes. Solventum aims to continue advancing solutions that improve patient outcomes and support healthcare professionals.
